Name
bloods_serumgluc
Label
Glucose, Serum
Units
mg/dL
Type
numeric
Visit number vs Glucose, Serum
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Baseline | 49 | 105.5 | ± 18.4 | 99.0 | 83.0 | 158.0 | - | 49 |
9-Month Followup | 43 | 105.1 | ± 26.4 | 99.0 | 51.0 | 188.0 | - | 43 |
18-Month Followup | 40 | 105.1 | ± 25.1 | 95.0 | 77.0 | 204.0 | - | 40 |
Randomized treatment arm vs Glucose, Serum
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 49 | 105.5 | ± 18.4 | 99.0 | 83.0 | 158.0 | - | 49 |
Laparoscopic Gastric Banding (LGB) | 28 | 101.1 | ± 13.7 | 97.0 | 83.0 | 139.0 | - | 28 |
Continuous Positive Airway Pressure (CPAP) | 21 | 111.4 | ± 22.3 | 104.0 | 85.0 | 158.0 | - | 21 |
Randomized treatment arm vs Glucose, Serum
9-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 43 | 105.1 | ± 26.4 | 99.0 | 51.0 | 188.0 | - | 43 |
Laparoscopic Gastric Banding (LGB) | 25 | 103.8 | ± 24.3 | 99.0 | 79.0 | 188.0 | - | 25 |
Continuous Positive Airway Pressure (CPAP) | 18 | 106.9 | ± 29.6 | 99.0 | 51.0 | 183.0 | - | 18 |
Randomized treatment arm vs Glucose, Serum
18-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 40 | 105.1 | ± 25.1 | 95.0 | 77.0 | 204.0 | - | 40 |
Laparoscopic Gastric Banding (LGB) | 24 | 95.5 | ± 12.3 | 93.0 | 77.0 | 139.0 | - | 24 |
Continuous Positive Airway Pressure (CPAP) | 16 | 119.5 | ± 32.1 | 112.0 | 88.0 | 204.0 | - | 16 |
Age of the participant vs Glucose, Serum
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 49 | 105.5 | ± 18.4 | 99.0 | 83.0 | 158.0 | - | 49 |
27.0 to 45.0 years | 13 | 106.5 | ± 23.2 | 97.0 | 83.0 | 158.0 | - | 13 |
46.0 to 50.0 years | 12 | 101.8 | ± 13.0 | 100.0 | 86.0 | 138.0 | - | 12 |
51.0 to 56.0 years | 12 | 104.1 | ± 15.3 | 97.5 | 87.0 | 140.0 | - | 12 |
57.0 to 65.0 years | 12 | 109.7 | ± 21.2 | 104.0 | 85.0 | 155.0 | - | 12 |
Age of the participant vs Glucose, Serum
9-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 43 | 105.1 | ± 26.4 | 99.0 | 51.0 | 188.0 | - | 43 |
28.0 to 47.0 years | 11 | 107.0 | ± 30.1 | 98.0 | 79.0 | 183.0 | - | 11 |
47.0 to 52.0 years | 11 | 105.6 | ± 31.0 | 99.0 | 80.0 | 188.0 | - | 11 |
52.0 to 58.0 years | 11 | 100.9 | ± 29.7 | 97.0 | 51.0 | 162.0 | - | 11 |
58.0 to 65.0 years | 10 | 107.1 | ± 12.6 | 101.5 | 92.0 | 127.0 | - | 10 |
Age of the participant vs Glucose, Serum
18-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 40 | 105.1 | ± 25.1 | 95.0 | 77.0 | 204.0 | - | 40 |
29.0 to 46.0 years | 10 | 111.3 | ± 28.5 | 101.5 | 77.0 | 158.0 | - | 10 |
47.0 to 52.0 years | 10 | 93.7 | ± 7.4 | 92.0 | 84.0 | 107.0 | - | 10 |
53.0 to 58.0 years | 10 | 112.7 | ± 35.7 | 100.0 | 85.0 | 204.0 | - | 10 |
58.0 to 65.0 years | 10 | 102.6 | ± 18.1 | 94.0 | 85.0 | 139.0 | - | 10 |
Gender of the participant vs Glucose, Serum
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 49 | 105.5 | ± 18.4 | 99.0 | 83.0 | 158.0 | - | 49 |
Male | 28 | 105.5 | ± 17.9 | 98.5 | 86.0 | 155.0 | - | 28 |
Female | 21 | 105.6 | ± 19.5 | 99.0 | 83.0 | 158.0 | - | 21 |
Gender of the participant vs Glucose, Serum
9-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 43 | 105.1 | ± 26.4 | 99.0 | 51.0 | 188.0 | - | 43 |
Male | 25 | 103.3 | ± 19.1 | 100.0 | 79.0 | 162.0 | - | 25 |
Female | 18 | 107.6 | ± 34.5 | 97.5 | 51.0 | 188.0 | - | 18 |
Gender of the participant vs Glucose, Serum
18-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 40 | 105.1 | ± 25.1 | 95.0 | 77.0 | 204.0 | - | 40 |
Male | 25 | 103.4 | ± 19.4 | 98.0 | 77.0 | 158.0 | - | 25 |
Female | 15 | 107.9 | ± 33.0 | 93.0 | 84.0 | 204.0 | - | 15 |
Race of the participant vs Glucose, Serum
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 46 | 104.5 | ± 17.3 | 99.0 | 83.0 | 158.0 | - | 46 |
white | 35 | 104.5 | ± 17.3 | 99.0 | 83.0 | 158.0 | - | 35 |
american indian or alaska native | - | - | - | - | - | - | - | - |
black or african american | 9 | 106.2 | ± 20.1 | 102.0 | 85.0 | 140.0 | - | 9 |
asian | 2 | 98.0 | ± 1.4 | 98.0 | 97.0 | 99.0 | - | 2 |
native hawaiian or other pacific islander | - | - | - | - | - | - | - | - |
other | - | - | - | - | - | - | - | - |
multiple | - | - | - | - | - | - | - | - |
Race of the participant vs Glucose, Serum
9-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 40 | 105.2 | ± 27.0 | 99.0 | 51.0 | 188.0 | - | 40 |
white | 31 | 103.5 | ± 23.5 | 99.0 | 79.0 | 183.0 | - | 31 |
american indian or alaska native | - | - | - | - | - | - | - | - |
black or african american | 8 | 112.6 | ± 40.2 | 108.0 | 51.0 | 188.0 | - | 8 |
asian | 1 | 98.0 | - | 98.0 | 98.0 | 98.0 | - | 1 |
native hawaiian or other pacific islander | - | - | - | - | - | - | - | - |
other | - | - | - | - | - | - | - | - |
multiple | - | - | - | - | - | - | - | - |
Race of the participant vs Glucose, Serum
18-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 37 | 104.9 | ± 25.8 | 94.0 | 77.0 | 204.0 | - | 37 |
white | 29 | 104.2 | ± 21.5 | 96.0 | 77.0 | 158.0 | - | 29 |
american indian or alaska native | - | - | - | - | - | - | - | - |
black or african american | 7 | 109.9 | ± 42.1 | 93.0 | 85.0 | 204.0 | - | 7 |
asian | 1 | 92.0 | - | 92.0 | 92.0 | 92.0 | - | 1 |
native hawaiian or other pacific islander | - | - | - | - | - | - | - | - |
other | - | - | - | - | - | - | - | - |
multiple | - | - | - | - | - | - | - | - |